Vaccines, antibodies, cell and gene therapies, and the plants that make them are a national security priority. Most federal money for biologics comes through manufacturing partnerships, preparedness programs and research awards rather than ordinary bids, so it's easy to miss.
Open Purse checks whether your site is in an Opportunity Zone, today and on the new 2027–2036 map, and connects you with a manufacturing funding specialist. Opportunity Zone financing help available.
Yes. Many federal bids are reserved for small businesses, and research awards (SBIR/STTR) are only open to them.
A grant funds a project the government wants to support, and you don't deliver a product to the agency. A contract buys goods or services from you. Many companies use grants to develop a product and contracts to sell it.
It can. Investors who put capital gains into a facility in an Opportunity Zone get tax breaks, which can make your project easier to finance. Today's zones end December 31, 2026, and a new map runs 2027 to 2036. Open Purse checks whether your site qualifies.
Type your company into Open Purse. In about 20 seconds you'll see the open grants, bids, contracts coming up for re-bid, and partnership programs that fit you, each with a plain-English reason and a first step. Searching is free.